Barriers to optimal care and strategies to promote safe and optimal management of sick young infants during the COVID-19 pandemic: A multi-country formative research study

Background Essential health and nutrition services for pregnant women, newborns, and children, particularly in low- and middle-income countries (LMICs), are disrupted by the COVID-19 pandemic. This formative research was conducted at five LMICs to understand the pandemic’s impact on barriers to and mitigation for strategies of care-seeking and managing possible serious bacterial infection (PSBI) in young infants. Methods We used a convergent parallel mixed-method design to explore the possible factors influencing PSBI management, barriers, and facilitators at three levels: 1) national and local policy, 2) the health systems, public and private facilities, and 3) community and caregivers. We ascertained trends in service provision and utilisation across pre-lockdown, lockdown, and post-lockdown periods by examining facility records and community health worker registers. Results The pandemic aggravated pre-existing challenges in the identification of young infants with PSBI; care-seeking, referral, and treatment due to several factors at the policy level (limited staff and resource reallocation), health facility level (staff quarantine, sub-optimal treatment in facilities, limited duration of service availability, lack of clear guidelines on the management of sick young infants, and inadequate supplies of protective kits and essential medicines) and at the community level (travel restrictions, lack of transportation, and fear of contracting the infection in hospitals). Care-seeking shifted to faith healers, traditional and informal private sources, or home remedies. However, caregivers were willing to admit their sick young infants to the hospital if advised by doctors. A review of facility records showed low attendance (<50%) of sick young infants in the OPD/emergencies during lockdowns in Bangladesh, India (both sites) and Pakistan, but it gradually increased as lockdowns eased. Stakeholders suggested aspirational and pragmatic mitigation strategies. Conclusions We obtained useful insights on health system preparedness during catastrophes and strategies to strengthen services and improve utilisation regarding PSBI management. The current pandemic provides an opportunity for implementing various mitigation strategies at the policy, health system, and community levels to improve preparedness.

[1]  S. Cousens,et al.  Global, regional, and national causes of under-5 mortality in 2000–19: an updated systematic analysis with implications for the Sustainable Development Goals , 2021, The Lancet. Child & adolescent health.

[2]  M. Abera,et al.  Implementation research on management of sick young infants with possible serious bacterial infection when referral is not possible in Jimma Zone, Ethiopia: Challenges and solutions , 2021, PloS one.

[3]  R. Mukhopadhyay,et al.  Lessons from implementation research on community management of Possible Serious Bacterial Infection (PSBI) in young infants (0-59 days), when the referral is not feasible in Palwal district of Haryana, India , 2021, PloS one.

[4]  F. Esamai,et al.  Clinical signs of possible serious infection and associated mortality among young infants presenting at first-level health facilities , 2021, PloS one.

[5]  C. S. Wesseh,et al.  Disruptions in maternal and child health service utilization during COVID-19: analysis from eight sub-Saharan African countries , 2021, Health policy and planning.

[6]  A. Ayede,et al.  Management of possible serious bacterial infection in young infants where referral is not possible in the context of existing health system structure in Ibadan, South-west Nigeria , 2021, PloS one.

[7]  J. Lawn,et al.  Small and sick newborn care during the COVID-19 pandemic: global survey and thematic analysis of healthcare providers’ voices and experiences , 2021, BMJ Global Health.

[8]  W. Terefe,et al.  Innovative approach for potential scale-up to jump-start simplified management of sick young infants with possible serious bacterial infection when a referral is not feasible: Findings from implementation research. , 2021, PloS one.

[9]  M. Bhan,et al.  Management of possible serious bacterial infection in young infants closer to home when referral is not feasible: Lessons from implementation research in Himachal Pradesh, India , 2020, PloS one.

[10]  S. Soofi,et al.  Evaluating implementation of “management of Possible Serious Bacterial Infection (PSBI) when referral is not feasible” in primary health care facilities in Sindh province, Pakistan , 2020, PloS one.

[11]  Rutuja Patil,et al.  Feasibility of implementation of simplified management of young infants with possible serious bacterial infection when referral is not feasible in tribal areas of Pune district, Maharashtra, India , 2020, PloS one.

[12]  G. Agarwal,et al.  Identification and management of young infants with possible serious bacterial infection where referral was not feasible in rural Lucknow district of Uttar Pradesh, India: An implementation research , 2020, PloS one.

[13]  N. Walker,et al.  Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study , 2020, The Lancet Global Health.

[14]  M. Shahidullah,et al.  Managing possible serious bacterial infection of young infants where referral is not possible: Lessons from the early implementation experience in Kushtia District learning laboratory, Bangladesh , 2020, PloS one.

[15]  A. Nakimuli,et al.  Voices from the frontline: findings from a thematic analysis of a rapid online global survey of maternal and newborn health professionals facing the COVID-19 pandemic , 2020, BMJ Global Health.

[16]  A. Baqui,et al.  Provider performance and facility readiness for managing infections in young infants in primary care facilities in rural Bangladesh , 2020, PloS one.

[17]  A. Baqui,et al.  Caregiver acceptability of the guidelines for managing young infants with possible serious bacterial infections (PSBI) in primary care facilities in rural Bangladesh , 2020, PloS one.

[18]  S. Qazi,et al.  Feasibility of implementing the World Health Organization case management guideline for possible serious bacterial infection among young infants in Ntcheu district, Malawi , 2020, PloS one.

[19]  R. Bahl,et al.  Implementation of the WHO guideline on treatment of young infants with signs of possible serious bacterial infection when hospital referral is not feasible in rural Zaria, Nigeria: Challenges and solutions , 2020, PloS one.

[20]  A. Baqui,et al.  Early implementation of guidelines for managing young infants with possible serious bacterial infection in Bangladesh , 2019, BMJ Global Health.

[21]  Julie M. Herlihy,et al.  Population-based rates, timing, and causes of maternal deaths, stillbirths, and neonatal deaths in south Asia and sub-Saharan Africa: a multi-country prospective cohort study , 2019 .

[22]  S. Cousens,et al.  Simplified antibiotic regimens for treatment of clinical severe infection in the outpatient setting when referral is not possible for young infants in Pakistan (Simplified Antibiotic Therapy Trial [SATT]): a randomised, open-label, equivalence trial , 2016, The Lancet. Global health.

[23]  F. Esamai,et al.  Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open-label, equivalence trial , 2015, The Lancet.

[24]  F. Esamai,et al.  Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open-label, equivalence trial , 2015, The Lancet.

[25]  S. Cousens,et al.  Safety and efficacy of alternative antibiotic regimens compared with 7 day injectable procaine benzylpenicillin and gentamicin for outpatient treatment of neonates and young infants with clinical signs of severe infection when referral is not possible: a randomised, open-label, equivalence trial. , 2015, The Lancet. Global health.